Lite Strategy, Inc. (LITS) vs Microbot Medical Inc. (MBOT)

A side-by-side comparison of Lite Strategy, Inc. and Microbot Medical Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

LITS

Lite Strategy, Inc.

$49M

$1.43HealthcareDelayed quote: Oct 6, 2026, 11:54 AM EDT

MBOT

Microbot Medical Inc.

$51M

$1.12HealthcareDelayed quote: Oct 6, 2026, 11:55 AM EDT

Total return — LITS vs MBOT

growth of $100 · dividends reinvested · last 1y

LITS -69.1% (-69.1%/yr)MBOT -69.8% (-69.8%/yr)LITS compounded faster over this window

LITS MBOT

LITS vs MBOT: by the numbers

•MBOT is the larger company ($51M vs $49M market cap).
•Both run net losses; LITS's is the smaller (0.00% vs -4722.25% net margin).

Metrics side by side

Valuation

Metric	LITS	MBOT
P/S ratio	N/A	146.85
P/B ratio	1.17	0.74

Profitability

Metric	LITS	MBOT
Gross margin	0.00%	0.00%
Operating margin	0.00%	0.00%
Net margin	0.00%	-4722.25%
ROE	-170.94%	-23.70%
ROIC	-30.75%	-26.51%

Growth (annualized)

Metric	LITS	MBOT
Total return CAGR (5Y)	N/A	-31.63%

Go deeper

Full LITS analysis Full MBOT analysis Interactive comparison tool

Dig into the metrics

Lite Strategy ROE Microbot Medical ROE Lite Strategy operating margin Microbot Medical operating margin Lite Strategy revenue growth Microbot Medical revenue growth Lite Strategy free cash flow Microbot Medical free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.